Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Montelukast
Other

Montelukast

Tracked across 1 events · 6 articles · First seen May 19, 2026 · Last active May 20, 2026

Sentiment
70
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 70
Tech
Montelukast Repurposed for Cancer Immunotherapy
Impact: Montelukast, an existing FDA-approved drug, has been identified as a potential treatment for aggressive cancers by blocking the CysLTR1 molecule, which could significantly expand its market and therapeutic applications.
May 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Montelukast live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.